Risk-stratified versus Non-Risk-stratified Diagnostic Testing for Management of Suspected Acute Biliary Obstruction: Comparative Effectiveness, Costs, and the Role of MR Cholangiopancreatography

MLA

Stella K. Kang, et al. “Risk-Stratified versus Non-Risk-Stratified Diagnostic Testing for Management of Suspected Acute Biliary Obstruction: Comparative Effectiveness, Costs, and the Role of MR Cholangiopancreatography.” Radiology, vol. 284, no. 2, Mar. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e2a3faf607787527b5d6a050f1b564be&authtype=sso&custid=ns315887.

APA

Stella K. Kang, R. Scott Braithwaite, David Hoffman, Michelle I Kim, & Bart S. Ferket. (2017). Risk-stratified versus Non-Risk-stratified Diagnostic Testing for Management of Suspected Acute Biliary Obstruction: Comparative Effectiveness, Costs, and the Role of MR Cholangiopancreatography. Radiology, 284(2).

Chicago

Stella K. Kang, R. Scott Braithwaite, David Hoffman, Michelle I Kim, and Bart S. Ferket. 2017. “Risk-Stratified versus Non-Risk-Stratified Diagnostic Testing for Management of Suspected Acute Biliary Obstruction: Comparative Effectiveness, Costs, and the Role of MR Cholangiopancreatography.” Radiology 284 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e2a3faf607787527b5d6a050f1b564be&authtype=sso&custid=ns315887.